4-methoxyamphetamine has been researched along with Carotid Artery Narrowing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babuskina, I; Erglis, A; Jegere, S; Krievina, AK; Krievins, D; Kumsars, I; Latkovskis, G; Zarins, CK; Zellans, E; Zvaigzne, L | 1 |
| Fujioka, D; Kawabata, K; Kitta, Y; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Sugamata, W; Uematsu, M; Watanabe, K; Watanabe, Y | 1 |
1 trial(s) available for 4-methoxyamphetamine and Carotid Artery Narrowing
| Article | Year |
|---|---|
Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy.
Topics: Aged; Angina, Unstable; Carotid Stenosis; Cholesterol, LDL; Chronic Disease; Death; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Plaque, Atherosclerotic; Retrospective Studies; Ultrasonography | 2014 |
1 other study(ies) available for 4-methoxyamphetamine and Carotid Artery Narrowing
| Article | Year |
|---|---|
Coronary revascularization of patients with silent coronary ischemia may reduce the risk of myocardial infarction and cardiovascular death after carotid endarterectomy.
Topics: Aged; Carotid Stenosis; Coronary Artery Disease; Death; Endarterectomy, Carotid; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Myocardial Infarction; Prospective Studies; Risk Factors; Stroke; Treatment Outcome | 2022 |